DAPAGLIFLOZIN
- Product NDC
- 50090-7057
- 11-digit product format
- 500907057
- Labeler code
- 50090
- Product ID
- 50090-7057_593bc861-fc6b-408d-8a45-b08745301f02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DAPAGLIFLOZIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA202293
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-01-03
- Substance
- DAPAGLIFLOZIN PROPANEDIOL
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 887K2391VH | DAPAGLIFLOZIN PROPANEDIOL | 960404-48-2 | DAPAGLIFLOZIN PROPANEDIOL |
| 1ULL0QJ8UC | DAPAGLIFLOZIN | 461432-26-8 | DAPAGLIFLOZIN |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7057-0 | 50090705700 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-7057-0) | 2024-01-16 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| DAPAGLIFLOZIN | A-S Medication Solutions | 2024-06-28 | HUMAN PRESCRIPTION DRUG LABEL | 4 |